TCIM
ALPN

TIAA CREF Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

TIAA CREF Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,119
Closed -$35K – 3201
2016
Q1 		$35K Hold
2,119
– – ﹤0.01% 3073
2015
Q4 		$66K Buy
2,119
+1,094
+107% +$37.3K ﹤0.01% 3127
2015
Q3 		$53K Buy
+1,025
New +$67.3K ﹤0.01% 3092

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TIAA CREF Investment Management's ALPN Position: Q2 2016 in Review

TIAA CREF Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2016, closing a stake of 2,119 shares — an estimated $35K sold.

TIAA CREF Investment Management first reported a position in ALPN in Q3 2015 and held it in 3 quarters. The position peaked at $66K in Q4 2015. 47 funds tracked by Wall St. Rank hold ALPN as of Q2 2016.

  • TIAA CREF Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2016 after selling out during the quarter.
  • TIAA CREF Investment Management sold 2,119 Alpine Immune Sciences Inc shares in Q2 2016, an estimated $35K.
  • TIAA CREF Investment Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 3 quarters.
  • TIAA CREF Investment Management's Alpine Immune Sciences Inc position peaked at $66K in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2016.

Based on TIAA CREF Investment Management's 13F filing for Q2 2016, filed 11 Aug 2016.